Cytosorbents Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cytosorbents Corp (Nasdaq: CTSO) on September 18, 2023. The filing discloses the entry into a material definitive agreement regarding the employment of the Company's Chief Financial Officer (CFO).
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes and Executive Compensation
Following the departure of former CFO Alexander D'Amico, the Company entered into a new Employment Agreement with Ms. Kathleen P. Bloch, effective September 18, 2023. This agreement replaces a prior consulting arrangement and extends through December 31, 2025. Key compensation terms include:
- Base Salary: $425,000 annually, retroactive to September 2, 2023.
- Cash Bonus: Eligible for an annual bonus up to 45% of base salary, at the discretion of the CEO.
- Restricted Stock Units (RSUs): Grant of 45,000 RSUs with the following vesting schedule:
- 25,000 RSUs vest immediately on the grant date.
- 10,000 RSUs vest on the first anniversary.
- 10,000 RSUs vest on the second anniversary.
- Stock Options: Incentive stock option to purchase 30,000 shares at fair market value on the grant date, vesting as follows:
- 10,000 options vest immediately.
- 10,000 options vest on the first anniversary.
- 10,000 options vest on the second anniversary.
Outlook, Risks, and Contingencies
The filing references an ongoing investigation into the former CFO, Mr. D'Amico, previously disclosed in August 2023. The appointment of Ms. Bloch is intended to provide continuity in the CFO role. No specific financial guidance or forward-looking revenue projections are included in this report.
Investor Verification Checklist
- Verify the total equity value of the 45,000 RSUs and 30,000 options based on the grant date fair market value.
- Review the full text of the Employment Agreement (Exhibit 10.1) for termination provisions and severance details.
- Monitor subsequent filings for updates regarding the investigation into the former CFO.
- Confirm the impact of the retroactive salary adjustment on the Company's immediate cash burn rate.